Mazahir Alimohamed
Stock Analyst at Oppenheimer
(1.83)
# 3,271
Out of 4,455 analysts
3
Total ratings
66.7%
Success rate
6.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mazahir Alimohamed
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Maintained: Buy | $22 | $7.40 | +197.30% | 1 | Jun 22, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $50 | $31.88 | +56.84% | 1 | Jun 17, 2026 | |
| IKT Inhibikase Therapeutics | Initiated Coverage: Buy | $5 | $1.91 | +161.78% | 1 | Jun 10, 2026 |
BridgeBio Oncology Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $22
Current: $7.40
Upside: +197.30%
Tyra Biosciences
Jun 17, 2026
Maintained: Buy
Price Target: $50
Current: $31.88
Upside: +56.84%
Inhibikase Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.91
Upside: +161.78%